We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fetal Membrane Repair Sealant Inspired by Mussel Adhesive

By HospiMedica International staff writers
Posted on 09 Feb 2010
A tissue sealant inspired by the marine mussels' ability to stick to surfaces under wet conditions has shown promise in the repair of defects in human fetal membranes, according to a new study.

Researchers at Northwestern University (Evanston, IL, USA) and University Hospital Zurich (Switzerland) developed the mussel-mimetic tissue sealant, essentially a simple synthetic polymer containing dihydroxyphenylalanine (DOPA) and a catalyst that when combined form a sealant gel in 10 to 20 seconds. More...
To test the material, the researchers punched holes three millimeters wide into human fetal tissue (in vitro) to replicate the tiny holes found in fetal membrane defects.

The researchers then applied a fibrin glue and three types of in situ forming poly(ethylene glycol) (PEG) based polymer hydrogels, and tested them for acute toxicity on direct contact with fetal membranes for 24 hours; for the determination of elution toxicity, extracts of sealants were incubated on amnion cell cultures for 72 hours. Both bonding and toxicity were assessed through morphologic and biochemical analysis, demonstrating that the mussel-inspired sealant had the best results in both categories. The study was published in the January 2010 issue of the American Journal of Obstetrics & Gynecology.

"We tested our mussel-inspired sealant on living fetal tissue and found it was both biocompatible and effective at sealing the tiny holes -- two features essential in such a material,” said coauthor Phillip Messersmith, Ph.D., a professor of biomedical engineering at Northwestern.

The fetal membrane is the structure that surrounds the developing fetus; defects in the membrane result either from incisions during endoscopic fetal surgeries used in the treatment of some birth defects, or premature and spontaneous ruptures in the fetal sac. These ruptures can lead to the leakage of amniotic fluid, resulting in premature labor or termination of the pregnancy.

The foot of the common mussel (Mytilus edulis) produces adhesive glue that keeps the shelled organism anchored to rocks and other objects, allowing them to withstand the extreme pounding of waves. Chemical analysis of this natural, waterproof glue have shown that the key to its adhesiveness is a family of unique proteins called mussel adhesive proteins, which contain a high concentration of DOPA.

Related Links:
Northwestern University
University Hospital Zurich




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.